SEC Form 4 · accession 0001437749-17-019827

Proto Labs Inc · PRLB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Officer — VP/GM & Managing Director-EMEA

Period of report

Nov 22, 2017

Accepted (ET)

Nov 27, 2017 · 5:33 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001443669

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Nov 22, 2017	M	7,341	$78.59	A	11,640	D
Common Stock	Nov 22, 2017	M	1,898	$67.15	A	13,538	D
Common Stock	Nov 22, 2017	M	1,891	$57.88	A	15,429	D
Common Stock^F1	Nov 22, 2017	S	13,556	$92.0708	D	1,873	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F2	$78.59	Nov 22, 2017	M	7,341	D	—	Feb 13, 2024	Common Stock	7,341	4,894	D
Employee Stock Option (right to buy)^F3	$67.15	Nov 22, 2017	M	1,898	D	—	Feb 9, 2025	Common Stock	1,898	2,847	D
Employee Stock Option (right to buy)^F4	$57.88	Nov 22, 2017	M	1,891	D	—	Feb 8, 2026	Common Stock	1,891	7,564	D

F1Reflects the weighted average price of 13,556 shares of common stock of Proto Labs, Inc. sold by the reporting person on November 22, 2017 with sale prices ranging from $91.50 to $92.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2The option vests as to 20% of the shares in five annual installments beginning on February 13, 2015.
F3The option vests as to 20% of the shares in five annual installments beginning on February 13, 2016.
F4The option vests as to 20% of the shares in five annual installments beginning on February 13, 2017.